Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (2310)
All Articles published online
|
Jun 21, 2005 (publication date) through Apr 25, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Cheng HY, Wang X, Chen D, Xu AM, Jia YC. The value and limitation of transcatheter arterial chemoembolization in preventing recurrence of resected hepatocellular carcinoma. World J Gastroenterol 2005; 11(23): 3644-3646 [PMID: 15962394 DOI: 10.3748/wjg.v11.i23.3644] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v11/i23/3644.htm |
| Number | Citing Articles |
| 1 |
Jia-Zhou Ye, Yan-Yan Wang, Tao Bai, Jie Chen, Bang-De Xiang, Fei-Xiang Wu, Le-Qun Li. Surgical resection for hepatocellular carcinoma with portal vein tumor thrombus in the Asia-Pacific region beyond the Barcelona Clinic Liver Cancer treatment algorithms: a review and update. Oncotarget 2017; 8(54): 93258 doi: 10.18632/oncotarget.18735
|
| 2 |
Xuejun Kuang, Jiazhou Ye, Zhibo Xie, Tao Bai, Jie Chen, Wenfeng Gong, Lunan Qi, Jianhong Zhong, Liang Ma, Ningfu Peng, Bangde Xiang, Feixiang Wu, Guobin Wu, Haihong Ye, Changmiao Wang, Lunqun Li. Adjuvant transarterial chemoembolization to improve the prognosis of hepatocellular carcinoma following curative resection. Oncology Letters 2018; doi: 10.3892/ol.2018.9244
|
| 3 |
Masatoshi Kudo, Kazuho Imanaka, Nobuyuki Chida, Kohei Nakachi, Won-Young Tak, Tadatoshi Takayama, Jung-Hwan Yoon, Takeshi Hori, Hiromitsu Kumada, Norio Hayashi, Shuichi Kaneko, Hirohito Tsubouchi, Dong Jin Suh, Junji Furuse, Takuji Okusaka, Katsuaki Tanaka, Osamu Matsui, Michihiko Wada, Iku Yamaguchi, Toshio Ohya, Gerold Meinhardt, Kiwamu Okita. Phase III study of sorafenib after transarterial chemoembolisation in Japanese and Korean patients with unresectable hepatocellular carcinoma. European Journal of Cancer 2011; 47(14): 2117 doi: 10.1016/j.ejca.2011.05.007
|
| 4 |
Xiao-Ming Wang, Zhen-Yu Yin, Ren-Xiang Yu, You-Yuan Peng, Ping-Guo Liu, Guo-Yang Wu. Preventive effect of regional radiotherapy with phosphorus-32 glass microspheres in hepatocellular carcinoma recurrence after hepatectomy. World Journal of Gastroenterology 2008; 14(4): 518-523 doi: 10.3748/wjg.14.518
|
| 5 |
Hai‐Feng Liu, Li‐Qiu Zou, Xing‐Ru Lu, Ye Sheng, Qing Wang, Jiu‐Le Ding, Li Shi, Shui‐Qing Liu, Wei Xing. Diagnostic Efficacy of Contrast‐Enhanced MRI in Detecting Residual or Recurrent Hepatocellular Carcinoma After Transarterial Chemoembolization: A Systematic Review and Meta‐analysis. Journal of Magnetic Resonance Imaging 2020; 52(4): 1019 doi: 10.1002/jmri.26970
|
| 6 |
Yoji Kishi, Akio Saiura, Junji Yamamoto, Rintaro Koga, Makoto Seki, Ryo Morimura, Ryuji Yoshioka, Norihiro Kokudo, Toshiharu Yamaguchi. Repeat treatment for recurrent hepatocellular carcinoma: is it validated?. Langenbeck's Archives of Surgery 2011; 396(7): 1093 doi: 10.1007/s00423-011-0837-0
|
| 7 |
Jian Zhao, Yu Xie. Progress in research of hepatocellular carcinoma with tumor thrombus. World Chinese Journal of Digestology 2019; 27(20): 1239 doi: 10.11569/wcjd.v27.i20.1239
|
| 8 |
WENBO SHAO, FENGJUAN ZHANG, NING CONG, JINPENG LI, JINLONG SONG. Transarterial chemoembolization combined with sorafenib for advanced hepatocellular carcinoma. Oncology Letters 2014; 8(5): 2263 doi: 10.3892/ol.2014.2512
|
| 9 |
Jian-Jun Li, Jia-Sheng Zheng, Shi-Chang Cui, Xiong-Wei Cui, Cai-Xia Hu, Da Fang, Lin-Chao Ye. C-arm Lipiodol CT in transcatheter arterial chemoembolization for small hepatocellular carcinoma. World Journal of Gastroenterology 2015; 21(10): 3035-3040 doi: 10.3748/wjg.v21.i10.3035
|
| 10 |
Qiang Zuo, Hui Huang, Min Shi, Futing Zhang, Jiping Sun, Jianping Bin, Yulin Liao, Wangjun Liao. Multivariate Analysis of Several Molecular Markers and Clinicopathological Features in Postoperative Prognosis of Hepatocellular Carcinoma. The Anatomical Record 2012; 295(3): 423 doi: 10.1002/ar.21531
|
| 11 |
Ahmed Shehta, Ahmed Farouk, Ahmed Nabieh Elghawalby, Mohamed Elshobary, Ahmed Aboelenin, Amgad Fouad, Mahmoud Abdelwahab Ali. Outcomes of Hepatic Resection for Hepatocellular Carcinoma Associated with Portal Vein Invasion. Journal of Surgical Research 2021; 266: 269 doi: 10.1016/j.jss.2021.04.011
|
| 12 |
Freliska Lazuardi, Jacqueline Valencia, Shusen Zheng. Adjuvant transcatheter arterial chemoembolization after radical resection of hepatocellular carcinoma patients with tumor size less than 5 cm: a retrospective study. Scandinavian Journal of Gastroenterology 2019; 54(5): 617 doi: 10.1080/00365521.2019.1607896
|
| 13 |
Fumitoshi Hirokawa, Koji Komeda, Kohei Taniguchi, Mitsuhiro Asakuma, Tetsunosuke Shimizu, Yoshihiro Inoue, Shuji Kagota, Atsushi Tomioka, Kazuhiro Yamamoto, Kazuhisa Uchiyama. Is Postoperative Adjuvant Transcatheter Arterial Infusion Therapy Effective for Patients with Hepatocellular Carcinoma who Underwent Hepatectomy? A Prospective Randomized Controlled Trial. Annals of Surgical Oncology 2020; 27(11): 4143 doi: 10.1245/s10434-020-08699-w
|
| 14 |
Zhendong Gao, Gang Du, Yuguang Pang, Zhihao Fu, Chongzhong Liu, Yi Liu, Binghai Zhou, Du Kong, Binyao Shi, Zhengcheng Jiang, Bin Jin. Adjuvant transarterial chemoembolization after radical resection contributed to the outcomes of hepatocellular carcinoma patients with high-risk factors. Medicine 2017; 96(33): e7426 doi: 10.1097/MD.0000000000007426
|
| 15 |
Jian‐Hong Zhong, Le‐Qun Li. Postoperative adjuvant transarterial chemoembolization for participants with hepatocellular carcinoma: A meta‐analysis. Hepatology Research 2010; 40(10): 943 doi: 10.1111/j.1872-034X.2010.00710.x
|
| 16 |
Takamasa Ohki, Koki Sato, Mayuko Kondo, Eriko Goto, Takahisa Sato, Yuji Kondo, Masatoshi Akamatsu, Shinpei Sato, Hideo Yoshida, Yukihiro Koike, Shuntaro Obi. Impact of Adverse Events on the Progression-Free Survival of Patients with Advanced Hepatocellular Carcinoma Treated with Lenvatinib: A Multicenter Retrospective Study. Drugs - Real World Outcomes 2020; 7(2): 141 doi: 10.1007/s40801-020-00179-7
|
| 17 |
Peng Sheng Yi, Yong Li, Shu Yan, Bin Wu, Chuan Lan, Jian Shui Li. Surgery combined with post-operative trancatheter arterial chemoembolization improves survival of intermediate hepatocellular carcinoma. Scandinavian Journal of Gastroenterology 2019; 54(2): 240 doi: 10.1080/00365521.2019.1577487
|
| 18 |
Ke-Yue Li, Shuai-Min Zhang, Cheng-Xian Shi, Ke-Li Tang, Jian-Zhao Huang. Effect of prophylactic transcatheter arterial chemoembolization on hepatocellular carcinoma with microvascular invasion after R0 resection. A case-control study. Sao Paulo Medical Journal 2020; 138(1): 60 doi: 10.1590/1516-3180.2019.0042.r1.05072019
|
| 19 |
H.-J. Song, J.-Y. Cheng, S.-L. Hu, G.-Y. Zhang, Y. Fu, Y.-J. Zhang. Value of 18F-FDG PET/CT in detecting viable tumour and predicting prognosis of hepatocellular carcinoma after TACE. Clinical Radiology 2015; 70(2): 128 doi: 10.1016/j.crad.2014.09.020
|
| 20 |
Zhao Liu, Jin-Ming Fan, Chen He, Zhi-Fan Li, Yong-Sheng Xu, Zhao Li, Hai-Feng Liu, Jun-Qiang Lei. Utility of diffusion weighted imaging with the quantitative apparent diffusion coefficient in diagnosing residual or recurrent hepatocellular carcinoma after transarterial chemoembolization: a meta-analysis. Cancer Imaging 2020; 20(1) doi: 10.1186/s40644-019-0282-9
|
| 21 |
Hye Ok Kim, Jae Seung Kim, Yong Moon Shin, Jin-Sook Ryu, Yung Sang Lee, Seung Gyu Lee. Evaluation of Metabolic Characteristics and Viability of Lipiodolized Hepatocellular Carcinomas Using18F-FDG PET/CT. Journal of Nuclear Medicine 2010; 51(12): 1849 doi: 10.2967/jnumed.110.079244
|
| 22 |
Takamasa Ohki, Koki Sato, Mari Yamagami, Daisaku Ito, Tomoharu Yamada, Koki Kawanishi, Kentaro Kojima, Michiharu Seki, Nobuo Toda, Kazumi Tagawa. Efficacy of Transcatheter Arterial Chemoembolization Followed by Sorafenib for Intermediate/Advanced Hepatocellular Carcinoma in Patients in Japan: A Retrospective Analysis. Clinical Drug Investigation 2015; 35(11): 751 doi: 10.1007/s40261-015-0333-3
|
| 23 |
Jian Zhang, Chunyan Fang, Meihua Qu, Huina Wu, Xuejuan Wang, Hongan Zhang, Hui Ma, Zhaolin Zhang, Yongxue Huang, Lihong Shi, Shujuan Liang, Zhiqin Gao, Weiguo Song, Xuejian Wang. CD13 Inhibition Enhances Cytotoxic Effect of Chemotherapy Agents. Frontiers in Pharmacology 2018; 9 doi: 10.3389/fphar.2018.01042
|
| 24 |
Wei Liu, Kun Wang, Quan Bao, Yi Sun, Bao-Cai Xing. Hepatic resection provided long-term survival for patients with intermediate and advanced-stage resectable hepatocellular carcinoma. World Journal of Surgical Oncology 2016; 14(1) doi: 10.1186/s12957-016-0811-y
|
| 25 |
Sibu P. Kuruvilla, Gopinath Tiruchinapally, A. Colleen Crouch, Mohamed E. H. ElSayed, Joan M. Greve, Nicola Amodio. Dendrimer-doxorubicin conjugates exhibit improved anticancer activity and reduce doxorubicin-induced cardiotoxicity in a murine hepatocellular carcinoma model. PLOS ONE 2017; 12(8): e0181944 doi: 10.1371/journal.pone.0181944
|
| 26 |
Sangheun Lee, Jung Hyun Kang, Do Young Kim, Sang Hoon Ahn, Jun Yong Park, Beom Kyung Kim, Seung Up Kim, Kwang-Hyub Han. Prognostic factors of sorafenib therapy in hepatocellular carcinoma patients with failure of transarterial chemoembolization. Hepatology International 2017; 11(3): 292 doi: 10.1007/s12072-017-9792-3
|
| 27 |
Chong Zhong, Rong-ping Guo, Jin-qing Li, Ming Shi, Wei Wei, Min-shan Chen, Ya-qi Zhang. A randomized controlled trial of hepatectomy with adjuvant transcatheter arterial chemoembolization versus hepatectomy alone for Stage III A hepatocellular carcinoma. Journal of Cancer Research and Clinical Oncology 2009; 135(10): 1437 doi: 10.1007/s00432-009-0588-2
|
| 28 |
Eric C. Ehman, Sarah E. Umetsu, Michael A. Ohliger, Nicholas Fidelman, Linda D. Ferrell, Ben M. Yeh, Judy Yee, Thomas A. Hope. Imaging prediction of residual hepatocellular carcinoma after locoregional therapy in patients undergoing liver transplantation or partial hepatectomy. Abdominal Radiology 2016; 41(11): 2161 doi: 10.1007/s00261-016-0837-1
|
| 29 |
Takamasa Ohki, Mayuko Kondo, Yuki Karasawa, Satoshi Kawamura, Shuuya Maeshima, Kentaro Kojima, Michiharu Seki, Nobuo Toda, Yoshinobu Shioda, Kazumi Tagawa. Evaluation of the Efficacy of Sorafenib on Overall Survival in Patients with Hepatocellular Carcinoma using FT Rate: A Devised Index. Advances in Therapy 2017; 34(5): 1097 doi: 10.1007/s12325-017-0524-9
|
| 30 |
Wei-Bo Yu, Andrew Rao, Victor Vu, Lily Xu, Jian-Yu Rao, Jian-Xiong Wu. Management of centrally located hepatocellular carcinoma: Update 2016. World Journal of Hepatology 2017; 9(13): 627-634 doi: 10.4254/wjh.v9.i13.627
|
| 31 |
Joong‐Won Park, Deepak Amarapurkar, Yee Chao, Pei‐Jer Chen, Jean‐Francois H. Geschwind, Khean Lee Goh, Kwang‐Hyub Han, Masatoshi Kudo, Han Chu Lee, Rheun‐Chuan Lee, Laurentius A. Lesmana, Ho Yeong Lim, Seung Woon Paik, Ronnie T Poon, Chee‐Kiat Tan, Tawesak Tanwandee, Gaojun Teng, Ann‐Lii Cheng. Consensus recommendations and review by an International Expert Panel on Interventions in Hepatocellular Carcinoma (EPOIHCC). Liver International 2013; 33(3): 327 doi: 10.1111/liv.12083
|
| 32 |
Qizhen Huang, Kongying Lin, Lei Wang, Jianxing Zeng, Hongzhi Liu, Zongren Ding, Yongyi Zeng, Jingfeng Liu. <p>Postoperative Adjuvant Transarterial Chemoembolization Improves Short-Term Prognosis of Hepatocellular Carcinoma with Bile Duct Tumor Thrombus: A Propensity-Score Matching Study</p>. Cancer Management and Research 2020; : 9183 doi: 10.2147/CMAR.S270467
|
| 33 |
Chao Zhang, Xin Chen, Jukun Wang, Tao Luo. Diagnostic values of contrast-enhanced MRI and contrast-enhanced CT for evaluating the response of hepatocellular carcinoma after transarterial chemoembolisation: a meta-analysis. BMJ Open 2024; 14(4): e070364 doi: 10.1136/bmjopen-2022-070364
|
| 34 |
Sibu P. Kuruvilla, Gopinath Tiruchinapally, Mahmoud ElAzzouny, Mohamed E. H. ElSayed. N‐Acetylgalactosamine‐Targeted Delivery of Dendrimer‐Doxorubicin Conjugates Influences Doxorubicin Cytotoxicity and Metabolic Profile in Hepatic Cancer Cells. Advanced Healthcare Materials 2017; 6(5) doi: 10.1002/adhm.201601046
|
| 35 |
Charing Ching-Ning Chong, Siu Tim Cheung, Yue-Sun Cheung, Anthony Wing-Hung Chan, Stephen Lam Chan, Simon Chun-Ho Yu, Paul Bo-San Lai. Novel biomarkers GEP/ABCB5 regulate response to adjuvant transarterial chemoembolization after curative hepatectomy for hepatocellular carcinoma. Hepatobiliary & Pancreatic Diseases International 2018; 17(6): 524 doi: 10.1016/j.hbpd.2018.10.003
|